Accumulation and activation-induced release of preformed Fas (CD95) ligand during the pathogenesis of experimental graft-versus-host disease.

Wasem, Christoph; Frutschi, Corina; Arnold, Diana; Vallan, Claudio; Lin, Tesu; Green, Douglas R; Mueller, Christoph; Brunner, Thomas (2001). Accumulation and activation-induced release of preformed Fas (CD95) ligand during the pathogenesis of experimental graft-versus-host disease. The journal of immunology, 167(5), pp. 2936-2941. American Association of Immunologists 10.4049/jimmunol.167.5.2936

[img] Text
2936.full.pdf - Published Version
Restricted to registered users only
Available under License Publisher holds Copyright.

Download (779kB) | Request a copy

Fas (CD95/APO-1) ligand (FasL)-mediated cytotoxicity has been implicated in tissue destruction in a variety of diseases, including acute graft-vs-host disease (GVHD). In this study, we have analyzed FasL expression and regulation during the course of experimental murine acute GVHD. Although activation-induced FasL-mediated cytotoxicity in control T cells was sensitive to the immunosuppressant cyclosporin A, we observed that functional FasL expression of GVHD T cells became increasingly cyclosporin A unresponsive. This was found to be the result of a massive in vivo accumulation and intracellular storage of FasL protein and its release in a transcription- and protein synthesis-independent manner. Immunohistochemistry analysis of FasL expression in situ revealed accumulation of FasL-expressing cells in the spleen, the liver, and small intestine, with a typical cytoplasmic and granular expression pattern. Thus, we conclude that the release of preformed FasL by infiltrating donor T cells may contribute to recipient tissue damage during the pathogenesis of acute GVHD.

Item Type:

Journal Article (Original Article)

Division/Institute:

04 Faculty of Medicine > Service Sector > Institute of Pathology

UniBE Contributor:

Vallan, Claudio, Müller, Christoph (C), Brunner, Thomas (A)

Subjects:

500 Science > 570 Life sciences; biology
600 Technology > 610 Medicine & health

ISSN:

0022-1767

Publisher:

American Association of Immunologists

Language:

English

Submitter:

Christoph Müller

Date Deposited:

23 Sep 2022 10:39

Last Modified:

29 Mar 2023 23:38

Publisher DOI:

10.4049/jimmunol.167.5.2936

PubMed ID:

11509642

BORIS DOI:

10.48350/173165

URI:

https://boris.unibe.ch/id/eprint/173165

Actions (login required)

Edit item Edit item
Provide Feedback